SEP-363856 is a novel antipsychotic drug, the exact mechanism of action of which is not clear. At present, it is believed that the mechanism of action of sep-363856 is different from that of previous antipsychotic drugs, it does not play a pharmacological role by antagonizing dopamine D2 receptor, but by activating 5-hydroxytryptamine 1A (5-HT1A) receptor and trace amine-associated receptor 1 (TAAR1). Recently, SEP-363856 has received breakthrough therapy designation of the US Food and Drug Administration for the treatment of adult patients with schizophrenia. In this paper, breakthrough therapy designation, the pharmacological mechanism, pharmacokinetics, drug-drug interaction, clinical application, safety and tolerance of SEP-363856 are reviewed.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |